Medicare Advantage and Prior Authorization Resources

As the Medicare Advantage (MA) program continues to grow, with more than half of eligible beneficiaries enrolled in MA as of 2024, AMRPA is committed to ensuring that all patients, regardless of their choice of payer, have robust access to medically necessary inpatient rehabilitation care. AMRPA prioritizes engagement with federal policymakers and health plans to ensure appropriate enforcement and oversight of the program, and to minimize the burden of prior authorization and other MA plan practices on patients and providers in the rehabilitation setting.  

For questions regarding the MA program, prior authorization, or other issues of access to IRF care, please contact AMRPA staff. We also welcome reports from the field about plan denials, prior authorization burdens, and other current trends to inform our advocacy efforts.  

Below, please find important information on current Medicare Advantage regulations and AMRPA resources to assist hospitals, clinicians, and patients. Read AMRPA’s recent public comments on MA issues here.